Brahimi F - Search Results

1

The combi-targeting concept: evidence for the formation of a novel inhibitor in vivo.

Merayo N, Rachid Z, Qiu Q, Brahimi F, Jean-Claude BJ. Merayo N, et al. Among authors: brahimi f. Anticancer Drugs. 2006 Feb;17(2):165-71. doi: 10.1097/00001813-200602000-00007. Anticancer Drugs. 2006. PMID: 16428934

2

Inhibition of epidermal growth factor receptor-mediated signaling by "Combi-triazene" BJ2000, a new probe for Combi-Targeting postulates.

Brahimi F, Matheson SL, Dudouit F, McNamee JP, Tari AM, Jean-Claude BJ. Brahimi F, et al. J Pharmacol Exp Ther. 2002 Oct;303(1):238-46. doi: 10.1124/jpet.102.039099. J Pharmacol Exp Ther. 2002. PMID: 12235257

3

The combi-targeting concept: a novel 3,3-disubstituted nitrosourea with EGFR tyrosine kinase inhibitory properties.

Qiu Q, Dudouit F, Matheson SL, Brahimi F, Banerjee R, McNamee JP, Jean-Claude BJ. Qiu Q, et al. Among authors: brahimi f. Cancer Chemother Pharmacol. 2003 Jan;51(1):1-10. doi: 10.1007/s00280-002-0524-5. Epub 2002 Nov 1. Cancer Chemother Pharmacol. 2003. PMID: 12497200

4

The combi-targeting concept: chemical dissection of the dual targeting properties of a series of "combi-triazenes".

Rachid Z, Brahimi F, Katsoulas A, Teoh N, Jean-Claude BJ. Rachid Z, et al. Among authors: brahimi f. J Med Chem. 2003 Sep 25;46(20):4313-21. doi: 10.1021/jm030142e. J Med Chem. 2003. PMID: 13678409

5

The combi-targetinG concept: intracellular fragmentation of the binary epidermal growth factor (EGFR)/DNA targeting "combi-triazene" SMA41.

Matheson SL, Brahimi F, Jean-Claude BJ. Matheson SL, et al. Among authors: brahimi f. Biochem Pharmacol. 2004 Mar 15;67(6):1131-8. doi: 10.1016/j.bcp.2003.10.035. Biochem Pharmacol. 2004. PMID: 15006549

6

Multiple mechanisms of action of ZR2002 in human breast cancer cells: a novel combi-molecule designed to block signaling mediated by the ERB family of oncogenes and to damage genomic DNA.

Brahimi F, Rachid Z, Qiu Q, McNamee JP, Li YJ, Tari AM, Jean-Claude BJ. Brahimi F, et al. Int J Cancer. 2004 Nov 10;112(3):484-91. doi: 10.1002/ijc.20383. Int J Cancer. 2004. PMID: 15382076

7

[Combi-molecules: a global approach towards better chemoselectivity and chemosensitivity].

Matheson S, Qiu Q, Brahimi F, Dudouit F, Banerjee R, Rachid Z, Jean-Claude BJ. Matheson S, et al. Among authors: brahimi f. Bull Cancer. 2004 Dec;91(12):911-5. Bull Cancer. 2004. PMID: 15634632 Free article. French.

8

Synthesis of half-mustard combi-molecules with fluorescence properties: correlation with EGFR status.

Rachid Z, Brahimi F, Domarkas J, Jean-Claude BJ. Rachid Z, et al. Among authors: brahimi f. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1135-8. doi: 10.1016/j.bmcl.2004.12.015. Bioorg Med Chem Lett. 2005. PMID: 15686928

9

Mechanism of action of a novel "combi-triazene" engineered to possess a polar functional group on the alkylating moiety: evidence for enhancement of potency.

Brahimi F, Rachid Z, McNamee JP, Alaoui-Jamali MA, Tari AM, Jean-Claude BJ. Brahimi F, et al. Biochem Pharmacol. 2005 Aug 15;70(4):511-9. doi: 10.1016/j.bcp.2005.04.037. Biochem Pharmacol. 2005. PMID: 15982640

10

The combi-targeting concept: in vitro and in vivo fragmentation of a stable combi-nitrosourea engineered to interact with the epidermal growth factor receptor while remaining DNA reactive.

Qiu Q, Domarkas J, Banerjee R, Merayo N, Brahimi F, McNamee JP, Gibbs BF, Jean-Claude BJ. Qiu Q, et al. Among authors: brahimi f. Clin Cancer Res. 2007 Jan 1;13(1):331-40. doi: 10.1158/1078-0432.CCR-06-0812. Clin Cancer Res. 2007. PMID: 17200372

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters